Juan Carlos
Galofre Ferrater
Consultor Médico
Instituto de Investigación Sanitaria de Navarra
Pamplona, EspañaPublicacions en col·laboració amb investigadors/es de Instituto de Investigación Sanitaria de Navarra (23)
2024
-
Patients' Persistent Symptoms, Clinician Demographics, and Geo-Economic Factors Are Associated with Choice of Therapy for Hypothyroidism by European Thyroid Specialists: The “THESIS” Collaboration
Thyroid, Vol. 34, Núm. 4, pp. 429-441
-
Thyroid dysfunction caused by immune checkpoint inhibitors improves cancer outcomes
Endocrine-related cancer, Vol. 31, Núm. 10
-
Thyroid hormones for euthyroid patients with simple goiter growing over time: a survey of European thyroid specialists
Endocrine
-
Tracking dynamic evolution of low- and intermediate-risk differentiated thyroid cancer: Identification of individuals at risk of recurrence
Clinical Endocrinology, Vol. 101, Núm. 3, pp. 286-294
-
Treatment of Obesity with Thyroid hormones in Europe. Data from the THESIS* Collaboration
Journal of Endocrinological Investigation
2023
2022
-
Questionable High Free T4 Concentrations: When Confirming against an Alternative Method Is Not Enough
Clinical chemistry, Vol. 68, Núm. 9, pp. 1128-1132
-
Use of thyroid hormone in hypothyroid patients and euthyroid subjects in Spain: A THESIS* questionnaire survey
Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 7, pp. 520-529
2021
-
Evaluation of the role of thyroid scintigraphy in the differential diagnosis of thyrotoxicosis
Clinical Endocrinology, Vol. 94, Núm. 3, pp. 466-472
-
Thyroid cancer patients satisfaction at the management outcome: an analysis of the results of a nationwide survey in 485 subjects
BMC Health Services Research, Vol. 21, Núm. 1
-
Thyroid cancer patients’ view of clinician professionalism and multidisciplinary approach to their management
Journal of Multidisciplinary Healthcare, Vol. 14, pp. 1053-1061
2020
-
The extent of surgery for low-risk 1–4 cm papillary thyroid carcinoma: a catch-22 situation. A retrospective analysis of 497 patients based on the 2015 ATA Guidelines recommendation 35
Endocrine, Vol. 70, Núm. 3, pp. 538-543
-
Utilidad del test de TSH recombinante en el seguimiento de pacientes con cáncer diferenciado de tiroides según los resultados de tiroglobulina basal
Advances in Laboratory Medicine, Vol. 1, Núm. 1
-
Utility of recombinant human TSH stimulation test in the follow-up of patients with differentiated thyroid cancer depending on basal thyroglobulin results
Advances in Laboratory Medicine, Vol. 1, Núm. 1
2019
-
Circulating GDF11 levels are decreased with age but are unchanged with obesity and type 2 diabetes
Aging, Vol. 11, Núm. 6, pp. 1733-1744
-
Circulating concentrations of GDF11 are positively associated with TSH levels in humans
Journal of Clinical Medicine, Vol. 8, Núm. 6
-
Transient osteoporosis of the hip during pregnancy
Endocrinologia, Diabetes y Nutricion, Vol. 66, Núm. 9, pp. 588-591
2018
-
Prevalence of thyroid dysfunction in a Large Southern European Population. Analysis of modulatory factors. The APNA study
Clinical Endocrinology, Vol. 89, Núm. 3, pp. 367-375
2017
-
Management of a pregnant woman with thyrotropinoma: a case report and review of the literature
Gynecological Endocrinology, Vol. 33, Núm. 3, pp. 188-192
2016
-
La disfunción tiroidea en la era de la medicina de precisión
Endocrinologia y Nutricion, Vol. 63, Núm. 7, pp. 354-363